Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-08-30
2011-08-30
Solola, Taofiq A (Department: 1622)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S244000
Reexamination Certificate
active
08008308
ABSTRACT:
The present invention relates to phosphonate compounds, compositions containing them, processes for obtaining them, and their use for treating a variety of medical disorders, e.g., osteoporosis and other disorders of bone metabolism, cancer, viral infections, and the like.
REFERENCES:
patent: 1944530 (1934-01-01), Schonburg
patent: 5223263 (1993-06-01), Hostetler et al.
patent: 5376649 (1994-12-01), Pohjala et al.
patent: 5411947 (1995-05-01), Hostetler et al.
patent: 5463092 (1995-10-01), Hostetler et al.
patent: 5627185 (1997-05-01), Gosselin et al.
patent: 5672697 (1997-09-01), Buhr et al.
patent: 5792756 (1998-08-01), Starrett, Jr. et al.
patent: 5922695 (1999-07-01), Arimilli et al.
patent: 5977089 (1999-11-01), Arimilli et al.
patent: 6716825 (2004-04-01), Hostetler et al.
patent: 0 632 048 (1995-01-01), None
patent: 0 897 709 (1999-02-01), None
patent: 1280788 (1972-07-01), None
patent: WO 96/40088 (1996-12-01), None
patent: WO 99/08685 (1999-02-01), None
patent: WO 00/04032 (2000-01-01), None
Valiaeva et al., Antiviral Res., (published on the Web Oct. 1, 2009), vol. 84(3),pp. 254-259.
Valiaeva et al., Antiviral Res., (2006), vol. 72(1), pp. 10-19.
Jones and Bischofberger, “Minireview: Nucleotide Prodrugs,”Antiviral Res. (1995), 27:1-17, Elsevier Science B.V.
Meerbach et al., “Inhibitory Effects of Novel Nucleoside and Nucleotide Analogues on Epstein-Barr Virus Replication,”Antiviral Chem. Chemother. (1998), 9:275-282, International Medical Press.
Niemi et al., “Bisphosphonate Prodrugs: Synthesis and in vitro Evaluation of Novel Acyloxyalkyl Esters of Clodronic Acid,”J. Med. Chem. (1999), 42:5053-5058, American Chemical Society.
Notari, Robert E., “Prodrug Design,”Pharmac. Ther. (1981), 14:25-53, Pergamon Press Ltd.
Serafinowska et al., “Synthesis and in Vivo Evaluation of Prodrugs of 9-[2-(Phosphonomethoxy)ethoxy]adenine,”J. Med. Chem. (1995) 38:1372-1379.
Beadle James R.
Hostetler Karl Y.
Kini Ganesh D.
DLA Piper (LLP) US
Solola Taofiq A
The Regents of the University of California
LandOfFree
Phosphonate compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Phosphonate compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phosphonate compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2793817